Possible vaccine
-
“The biggest disclosure, and surprise, from the two company’s conference calls, was the suggestion that the pivotal trials might open in July, and then be fully recruited in August, and then have interim efficacy data in September,” wrote SVB Leerink analyst Daina Graybosch in a note out Thursday. “The ambition of this timeline is laudable, but seems challenging.”
-
Moderna has delayed its upcomg phase 3 and oxford/astra Zeneca which have already have a phase 3 going have sent out some disturbing messages that they have had mixed immune responses to their vaccine. These are the two main candidate companies.
I was trying to be optimistic that we will hit the winter with a potential winner but I’m having doubts now.